The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
A census of human cancer genes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focusing on cancer census genes [28], we observed such complex expression patterns for 26 of the current 513 cancer census genes (Additional file 1: Table S2).”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [28]
In the citing paper
“We noted that many of the boundaries of cancer driver genes were altered in specific histological subtypes (Fig. 3a, Supplementary Table 2).”
From Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pfam Protein Families Database
Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,007
Phospho‐tyrosine dependent protein–protein interaction network
Großmann, A., Benlasfer, N., Birth, P., Hegele, A., Wachsmuth, F., Apelt, L., & Stelzl, U. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145968 · Cited by 76
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Mishani, E., Abourbeh, G., Eiblmaier, M., & Anderson, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404326 · Cited by 76
Molecular Classification of Neuroendocrine Tumors of the Thymus
Dinter, H., Bohnenberger, H., Beck, J., Bornemann-Kolatzki, K., Schütz, E., Küffer, S., Klein, L., Franks, T. J., Roden, A. C., Emmert, A., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.04.015 · Cited by 75
Tissue, cell and stage specificity of (epi)mutations in cancers
Sieber, O. M., Tomlinson, S. R., & Tomlinson, I. P. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1674 · Cited by 76
Gandhi, M., Medvedovic, M., Stringer, J. R., & Nikiforov, Y. E. (2005) · Oncogene · doi:10.1038/sj.onc.1209268 · Cited by 75
Geyer, F. C., Berman, S., Marchiò, C., Burke, K. A., Guerini‐Rocco, E., Piscuoglio, S., Ng, C. K. Y., Pareja, F. G., Wen, H. Y., Hódi, Z., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.161 · Cited by 76
The genetic landscape of breast carcinomas with neuroendocrine differentiation
Marchiò, C., Geyer, F. C., Ng, C. K. Y., Piscuoglio, S., Filippo, M. R. D., Cupo, M., Schultheis, A. M., Lim, R. S., Burke, K. A., Guerini‐Rocco, E., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4837 · Cited by 78
Sivley, R. M., Kropski, J., Sheehan, J., Cogan, J., Dou, X., Blackwell, T. S., Phillips, J., Meiler, J., Bush, W. S., & Capra, J. A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.017 · Cited by 76
p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes
Pappas, K., Xu, J., Zairis, S., Resnick‐Silverman, L., Abate, F., Steinbach, N., Ozturk, S., Saal, L. H., Su, T., Cheung, P., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0089 · Cited by 77
DNA Mutations May Not Be the Cause of Cancer
Adjiri, A. (2017) · Oncology and Therapy · doi:10.1007/s40487-017-0047-1 · Cited by 76
Kim, M., Rhee, J., Choi, H., Kwon, A., Kim, J., Lee, D., Jekarl, D. W., Lee, S., Kim, Y., & Kim, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-15155-5 · Cited by 79
Somatic evolution and global expansion of an ancient transmissible cancer lineage
Baez‐Ortega, A., Gori, K. C., Strakova, A., Allen, J. L., Allum, K. M., Bansse-Issa, L., Bhutia, T. N., Bisson, J. L., Briceño, C., Domracheva, A. C., et al. (2019) · Science · doi:10.1126/science.aau9923 · Cited by 80
Self-citationAnandakrishnan, R., Varghese, R. T., Kinney, N. A., & Garner, H. R. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006881 · Cited by 74
Lazzari, L., Corti, G., Picco, G., Isella, C., Montone, M., Arcella, P., Durinikova, E., Zanella, E. R., Novara, L., Barbosa, F., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3440 · Cited by 74
Lochovsky, L., Zhang, J., Fu, Y., Khurana, E., & Gerstein, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv803 · Cited by 75
The butterfly effect in cancer: A single base mutation can remodel the cell
Hart, J. R., Zhang, Y., Liao, L., Ueno, L. A., Du, L., Jonkers, M., Yates, J. R., & Vogt, P. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424012112 · Cited by 74
ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer
Guo, Q., Grimmig, T., González, G., Giobbie‐Hurder, A., Berg, G., Carr, N., Wilson, B. J., Banerjee, P., Ma, J., Gold, J. S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003187 · Cited by 74
Barshir, R., Shwartz, O., Smoly, I. Y., & Yeger‐Lotem, E. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003632 · Cited by 77
The evolution and expression of virulence
Ebert, D., & Bull, J. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0012 · Cited by 75
TCR-like antibodies in cancer immunotherapy
He, Q., Liu, Z., Liu, Z., Lai, Y., Zhou, X., & Weng, J. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0788-4 · Cited by 78
Characterization of thyroid cancer driven by known and novel ALK fusions
Panebianco, F., Nikitski, A. V., Nikiforova, M. N., Kaya, C., Yip, L., Condello, V., Wald, A. I., Nikiforov, Y. E., & Chiosea, S. I. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0325 · Cited by 73
Pan, K., Qin, J., Li, S., Dai, W., Zhu, B., Jin, Y.-C., Yu, W., Yang, G., & Li, D. (2011) · Journal of Phycology · doi:10.1111/j.1529-8817.2011.01057.x · Cited by 73
Sundaram, S. K., Shankar, S., DeRoo, S. C., Iyer, M. K., Palanisamy, N., Chinnaiyan, A. M., & Kumar‐Sinha, C. (2012) · Neoplasia · doi:10.1593/neo.12914 · Cited by 73
Mutator phenotype in cancer: Timing and perspectives
Bielas, J. H., & Loeb, L. A. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20111 · Cited by 73
Oncogenic gene fusions in epithelial carcinomas
Prensner, J. R., & Chinnaiyan, A. M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.008 · Cited by 73
Liu, J., Zhang, Y., Lei, X. C., & Zhang, Z. (2008) · Genome biology · doi:10.1186/gb-2008-9-4-r69 · Cited by 74
Kodama, T., Newberg, J. Y., Kodama, M., Rangel, R., Yoshihara, K., Tien, J. C.-Y., Parsons, P. H., Wu, H., Finegold, M. J., Copeland, N. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606876113 · Cited by 72
Comparison of algorithms for the detection of cancer drivers at subgene resolution
Porta‐Pardo, E., Kamburov, A., Tamborero, D., Pons, T., Grases, D., Valencia, A., López-Bigas, N., Getz, G. A., & Godzik, A. (2017) · Nature Methods · doi:10.1038/nmeth.4364 · Cited by 72
Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma
Sarathi, A., & Palaniappan, A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5838-3 · Cited by 72
Ahmed, F., Ijaz, B., Ahmad, Z., Farooq, N., Sarwar, M. B., & Husnaın, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153168 · Cited by 73
Zuo, Z., Wang, P., Chen, X., Li, T., Ge, H., & Qian, D. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04352-9 · Cited by 75
Cheng, F., Liu, C., Lin, C.-C., Zhao, J., Jia, P., Li, W., & Zhao, Z. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004497 · Cited by 73
Genomic Aberrations in Lung Adenocarcinoma in Never Smokers
Job, B., Bernheim, A., Beau‐Faller, M., Camilleri‐Broët, S., Girard, P., Hofman, P. M., Mazières, J., Toujani, S., Lacroix, L., Laffaire, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015145 · Cited by 75
CanProVar: a human cancer proteome variation database
Li, J., Duncan, D. T., & Zhang, B. (2010) · Human Mutation · doi:10.1002/humu.21176 · Cited by 72
Detecting common copy number variants in high-throughput sequencing data by using JointSLM algorithm
Magi, A., Benelli, M., Yoon, S. C., Roviello, F., & Torricelli, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr068 · Cited by 72
Naturally Occurring Cancers in Dogs: Insights for Translational Genetics and Medicine
Alvarez, C. E. (2014) · ILAR Journal · doi:10.1093/ilar/ilu010 · Cited by 72
Sankhe, A. P., Dalal, K., Agarwal, V., & Sarve, P. (2016) · Journal of Religion and Health · doi:10.1007/s10943-016-0324-6 · Cited by 72
Alu distribution and mutation types of cancer genes
Zhang, W., Edwards, A., Fan, W., Deininger, P. L., & Zhang, K. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-157 · Cited by 72
Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2
Zhou, B., Ho, S. S., Greer, S. U., Spies, N., Bell, J. M., Zhang, X., Zhu, X., Arthur, J. G., Byeon, S., Pattni, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz169 · Cited by 72
Targeting the Human Cancer Pathway Protein Interaction Network by Structural Genomics
Huang, Y. J., Hang, D., Lu, L. J., Tong, L., Gerstein, M., & Montelione, G. T. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700550-mcp200 · Cited by 72
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia
Wang, J., Khiabanian, H., Rossi, D., Fabbri, G., Gattei, V., Forconi, F., Laurenti, L., Marasca, R., Poeta, G. D., Foà, R., et al. (2014) · eLife · doi:10.7554/elife.02869 · Cited by 71
Jelı́nek, J., Liang, S., Lu, Y., He, R. L., Ramagli, L. S., Shpall, E. J., Estecio, M. R., & Issa, J. J. (2012) · Epigenetics · doi:10.4161/epi.22552 · Cited by 71
Gnjatic, S., Wheeler, C., Ebner, M., Ritter, E., Murray, A., Altorki, N. K., Ferrara, C. A., Hepburne-Scott, H., Joyce, S., Koopman, J., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.016 · Cited by 71
Guerini‐Rocco, E., Hodi, Z., Piscuoglio, S., Ng, C. K. Y., Rakha, E. A., Schultheis, A. M., Marchiò, C., Paula, A. D. C., Filippo, M. R. D., Martelotto, L. G., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4566 · Cited by 71
Capp, J. (2005) · BioEssays · doi:10.1002/bies.20326 · Cited by 75
Proteomic Analysis of PAXgene-Fixed Tissues
Ergin, B., Meding, S., Langer, R., Kap, M., Viertler, C., Schott, C., Ferch, U., Riegman, P. H. J., Zatloukal, K., Walch, A. K., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100664e · Cited by 70
Genetic analysis of the kinome and phosphatome in cancer
Arena, S., Benvenuti, S., & Bardelli, A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5205-1 · Cited by 75
Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies
Stella, G. M., Luisetti, M., Inghilleri, S., Cemmi, F., Scabini, R., Zorzetto, M., & Pozzi, E. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.015 · Cited by 73
Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?
Dissous, C., & Grevelding, C. G. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.09.001 · Cited by 70
Bryant, A. J., Palma, C. A., Jayaswal, V., Yang, Y. W., Lutherborrow, M. A., & David, D. F. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-8 · Cited by 73
Deregulation of a Hox Protein Regulatory Network Spanning Prostate Cancer Initiation and Progression
Chen, J. L., Li, J., Kiriluk, K. J., Rosen, A. M., Paner, G. P., Antic, T., Lussier, Y. A., & Griend, D. J. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0373 · Cited by 70
Huang, A. Y., Zhang, Z., Ye, A. Y., Dou, Y., Yan, L., Yang, X., Zhang, Y., & Wei, L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx024 · Cited by 71
The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization
Bruno, A., Costantino, G., Sartori, L., & Radi, M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171107101035 · Cited by 73
Peerzada, M. N., Hamel, E., Bai, R., Supuran, C. T., & Azam, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107860 · Cited by 70
Czubak, K., Lewandowska, M. A., Klonowska, K., Roszkowski, K., Kowalewski, J., Figlerowicz, M., & Kozłowski, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4351 · Cited by 69
Klijn, C. N., Holstege, H. H., de Ridder, J., Liu, X., Reinders, M. J. T., Jonkers, J., & Wessels, L. F. A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1143 · Cited by 70
TopoGSA: network topological gene set analysis
Glaab, E., Baudot, A., Krasnogor, N., & Valencia, A. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq131 · Cited by 69
TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
Zhou, Z. M., Lyu, X., Wu, J., Yang, X., Wu, S., Zhou, J., Gu, X., Su, Z., & Chen, S. (2017) · Royal Society Open Science · doi:10.1098/rsos.170050 · Cited by 69
Brunet, M. A., Levesque, S. A., Hunting, D. J., Cohen, A. A., & Roucou, X. (2018) · Genome Research · doi:10.1101/gr.230938.117 · Cited by 75
Niedergethmann, M., Alves, F., Neff, J., Heidrich, B., Aramin, N., Li, L., Pilarsky, C. P., Grützmann, R., Allgayer, H., Post, S., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604031 · Cited by 68
Starr, T. K., Scott, P. M., Marsh, B. M., Zhao, L. Q., Than, B. L. N., O’Sullivan, M. G., Sarver, A. L., Dupuy, A. J., Largaespada, D. A., & Cormier, R. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018012108 · Cited by 68
Genomic landscape of metastatic colorectal cancer
Haan, J. C., Labots, M., Rausch, C. R., Koopman, M., Tol, J., Mekenkamp, L. J., van de Wiel, M. A., Israeli, D., Essen, H. F. H. V., van Grieken, N. C. T., et al. (2014) · Nature Communications · doi:10.1038/ncomms6457 · Cited by 68
Suzuki, A., Matsushima, K., Makinoshima, H., Sugano, S., Kohno, T., Tsuchihara, K., & Suzuki, Y. (2015) · Genome biology · doi:10.1186/s13059-015-0636-y · Cited by 68
Bioinformatics for personal genome interpretation
Capriotti, E., Nehrt, N. L., Kann, M. G., & Bromberg, Y. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr070 · Cited by 68
Protein Domain-Level Landscape of Cancer-Type-Specific Somatic Mutations
Yang, F., Petsalaki, E., Rolland, T., HILL, D. E., Vidal, M., & Roth, F. P. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004147 · Cited by 71
Comparative Analysis of Public Knowledge Bases for Precision Oncology
Pallarz, S., Benary, M., Lamping, M., Rieke, D. T., Starlinger, J., Sers, C., Wiegandt, D. L., Seibert, M., Ševa, J., Schäfer, R., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00371 · Cited by 67
Zhao, S., Liu, X., Jin, X., Ma, D., Xiao, Y., Shao, Z.-M., & Jiang, Y. (2019) · Theranostics · doi:10.7150/thno.35730 · Cited by 67
Identification of Drivers from Cancer Genome Diversity in Hepatocellular Carcinoma
Takai, A., Dang, H. T., & Wang, X. W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150611142 · Cited by 68
MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures
Niknafs, N., Kim, D., Kim, R., Diekhans, M., Ryan, M., Stenson, P. D., Cooper, D. N., & Karchin, R. (2013) · Human Genetics · doi:10.1007/s00439-013-1325-0 · Cited by 67
Qiu, Z., Zou, K., Zhuang, L., Qin, J., Li, H., Li, C., Zhang, Z., Chen, X., Cen, J., Meng, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27411 · Cited by 69
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
Yurkovich, J. T., Tian, Q., Price, N. D., & Hood, L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0273-6 · Cited by 73
Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer
Blagden, S. P. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00149 · Cited by 66
van Kester, M. S., Tensen, C. P., Vermeer, M. H., Dijkman, R., Mulder, A. A., Szuhai, K., Willemze, R., & van Doorn, R. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.270 · Cited by 66
Nagaraj, S. H., & Reverter, A. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-35 · Cited by 66
Local gene density predicts the spatial position of genetic loci in the interphase nucleus
Murmann, A. E., Gao, J., Encinosa, M., Gautier, M., Peter, M. E., Eils, R., Lichter, P., & Rowley, J. D. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.020 · Cited by 66
Genome-wide RNAi screens in Caenorhabditis elegans: impact on cancer research
Poulin, G. B., Nandakumar, R., & Ahringer, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208010 · Cited by 68
Glass, K., & Girvan, M. (2014) · Scientific Reports · doi:10.1038/srep04191 · Cited by 68
Low duplicability and network fragility of cancer genes
Rambaldi, D., Giorgi, F. M., Capuani, F., Ciliberto, A., & Ciccarelli, F. D. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.06.003 · Cited by 66
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
Yin, C., Yuan, C., Qu, Z., Guan, Q., Chen, H., & Wang, F. (2016) · Disease Markers · doi:10.1155/2016/1427849 · Cited by 68
Sato, K., Kawazu, M., Yamamoto, Y., Ueno, T., Kojima, S., Nagae, G., Abe, H., Soda, M., Oga, T., Kohsaka, S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1574 · Cited by 65
PRMT1 promotes pancreatic cancer growth and predicts poor prognosis
Song, C., Chen, T., He, L., Ma, N., Li, J., Rong, Y., Fang, Y., Liu, M., Xie, D., & Lou, W. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00435-1 · Cited by 65
Chen, S., Xie, Y., Cai, Y., Hu, H., He, M., Liu, L., Liao, C., Wang, Y., Wang, J., Ren, X., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1157 · Cited by 65
Mushtaq, A., Wu, P., & Naseer, M. M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108579 · Cited by 65
Iannelli, F., Collino, A., Sinha, S., Radaelli, E., Nicoli, P., D’Antiga, L., Sonzogni, A., Faivre, J., Buendia, M. A., Sturm, E., et al. (2014) · Nature Communications · doi:10.1038/ncomms4850 · Cited by 68
Transposon mutagenesis identifies genetic drivers of BrafV600E melanoma
Mann, M. B., Black, M. A., Jones, D. J., Ward, J. M., Yew, C. C. K., Newberg, J. Y., Dupuy, A. J., Rust, A. G., Bosenberg, M., McMahon, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3275 · Cited by 66
Reimand, J., Wagih, O., & Bader, G. D. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004919 · Cited by 71
Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer
Park, H., Cho, S., Kim, H., Na, D., Han, J. Y., Chae, J., Park, C., Park, O.-K., Min, S., Kang, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507491112 · Cited by 65
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events
Ashouri, A., Sayin, V. I., den Eynden, J. V., Singh, S. X., Papagiannakopoulos, T. Y., & Larsson, E. (2016) · Nature Communications · doi:10.1038/ncomms13197 · Cited by 66
American Cancer Society ( ACS )
Higgins, C. S., Martin, T. J., & Roginski, A. M. (2014) · Wiley eBooks · doi:10.1002/9781118660584.ese0105 · Cited by 65
Stevens, A., Hanson, D., Whatmore, A., Destenaves, B., Chatelain, P., & Clayton, P. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-547 · Cited by 65
A Comparative Genomic Approach for Identifying Synthetic Lethal Interactions in Human Cancer
Deshpande, R., Asiedu, M. K., Klebig, M., Sutor, S., Kuzmin, E., Nelson, J., Piotrowski, J., Ho Shin, S., Yoshida, M., Costanzo, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3956 · Cited by 64
Implications of personalized medicine—perspective from a cancer center
Tursz, T., André, F., Lazar, V., Lacroix, L., & Soria, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.222 · Cited by 64
Clarke, C. N., Katsonis, P., Hsu, T., Koire, A. M., Silva, A. M., Christakis, I. A., Williams, M. D., Kutahyalioglu, M., Kwatampora, L. J., Xi, Y., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00043 · Cited by 64
Junnila, S., Kokkola, A., Karjalainen‐Lindsberg, M., Puolakkainen, P. A., & Monni, O. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-73 · Cited by 64
The GENCODE exome: sequencing the complete human exome
Coffey, A. J., Kokocinski, F., Calafato, M., Scott, C., Palta, P., Drury, E., Joyce, C. J., LeProust, E. M., Harrow, J., Hunt, S. E., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.28 · Cited by 64
Self-citationStructure‐energy‐based predictions and network modelling of RASopathy and cancer missense mutations
Kiel, C., & Serrano, L. G. (2014) · Molecular Systems Biology · doi:10.1002/msb.20145092 · Cited by 67
Network-based Identification of Novel Cancer Genes
Östlund, G., Lindskog, M., & Sonnhammer, E. L. L. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900227-mcp200 · Cited by 64
High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes
Atak, Z. K., Keersmaecker, K. D., Gianfelici, V., Geerdens, E., Vandepoel, R., Pauwels, D., Porcu, M., Lahortiga, I., Brys, V., Dirks, W. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038463 · Cited by 71
Domain landscapes of somatic mutations in cancer
Nehrt, N. L., Peterson, T. A., Park, D., & Kann, M. G. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s4-s9 · Cited by 65
Guerini‐Rocco, E., Piscuoglio, S., Ng, C. K. Y., Geyer, F. C., Filippo, M. R. D., Eberle, C. A., Akram, M. M., Fusco, N., Ichihara, S., Sakr, R. A., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4691 · Cited by 65
Metadata
- Authors
- Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Institute of Cancer Research (GB)
- Corresponding author
- Stratton, Michael R.
- Venue
- Nature Reviews Cancer
- Published
- 2004-03
- Volume
- 4
- Issue
- 3
- Pages
- 177-183
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2665285
- OpenAlex
- W2102140136
- Cited by
- 3,184
- References
- 44
- Citations by year
- 2026: 13 · 2025: 51 · 2024: 71 · 2023: 134 · 2022: 109 · 2021: 143 · 2020: 166 · 2019: 204 · 2018: 237 · 2017: 190 · 2016: 191 · 2015: 228 · 2014: 201 · 2013: 208 · 2012: 164
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- cancer genes, oncogenes, tumor suppressor, oncogenic mutations, mutation frequency, human genome, protein domains, cancer classification
- MeSH terms
- Genes, Humans, Mutation, Neoplasms, Oncogenes, Genome, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review